Vertex Pharmaceuticals EVP/CMO Carmen Bozic Sells 1,020 Shares

What Happened Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), sold 1,020 shares on 2026-06-18 at $462.17 per share, generating proceeds of approximately $471,413. The transaction was a sale (S) reported on a Form 4.

Key Details

• Transaction date and price: 2026-06-18, 1,020 shares sold at $462.17 each.
• Total value: ~$471,413.
• Transaction type: Sale (reported as "open market or private sale").
• Shares owned after transaction: Not specified in the filing.
• Footnote: Sale executed under a company-approved Rule 10b5-1 trading plan entered 11/20/2025.
• Filing timeliness: Form 4 filed 2026-06-23 (five days after the trade). Form 4s are typically due within two business days, so this filing appears late.

Context Insider sales can be routine (e.g., pre-set 10b5-1 plans, tax or diversification needs) and do not necessarily signal a change in company outlook. Because this sale was made under a 10b5-1 plan, it was pre-arranged and is less indicative of contemporaneous insider sentiment. Note that purchases generally carry more weight as positive signals than routine sales.